Inflammation and adaptive immunity in Parkinson's disease. - Wikidata - thesis-toulmin - TriplyDB

Inflammation and adaptive immunity in Parkinson's disease.

Inflammation and adaptive immunity in Parkinson's disease.

http://www.wikidata.org/entity/Q37982378

about

The biomarkers of immune dysregulation and inflammation response in Parkinson disease Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease How Can We Treat Cancer Disease Not Cancer Cells?Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis.Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease.Phenome-based gene discovery provides information about Parkinson's disease drug targets A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.Association of Parkinson disease with structural and regulatory variants in the HLA region Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity α-Synuclein in Parkinson's disease.Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Innate inflammation in Parkinson's disease.The role of inflammation in sporadic and familial Parkinson's disease.Integrating pathways of Parkinson's disease in a molecular interaction map.Animal models of neurodegenerative diseases.Inflammation in neurodegenerative diseases--an update.Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.Beyond muscles: The untapped potential of creatine.Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model.

P2860

Q26738459-7DB299C1-025B-465A-BF5F-B54766545E71 Q26770676-07176836-5424-4F73-A55E-3121135BC20C Q26849232-15EA6D09-C2FC-49BD-B26C-020E42E43CB3 Q27015811-F691712D-CAD3-4F8A-9418-8B870E2D633E Q28079206-09617323-4DF4-4017-8FD3-9E322921FC97 Q28558823-16E83354-25E5-4147-AD51-8A80FFA127B1 Q33920647-C8CAE0C5-0BBC-4C9A-812A-D341C88777DE Q35058359-FAF48A0E-6B2C-4010-B835-19AAC501E8C2 Q35059951-1E2ED34D-E12E-40F3-B5AD-74D4196CE8E0 Q35068792-5C3EF3A1-BB9F-4093-BD12-EAEB430D7A37 Q35246024-17832BCA-4C70-4166-B0E3-5E5086020EAA Q35285839-B1495DBA-DA1D-4327-8288-058BB7BE9DBD Q35514746-E20B9354-E77A-4601-8CEE-561C98154FA5 Q36109874-F03072BA-A9FE-4FB0-ACAC-07B1089A6BBE Q36120753-3C72EE3D-963C-4CBD-A56E-487ABA2EB42C Q36326816-1A58BBB5-52A1-4C67-A1D4-A9F37CFE5F33 Q36346401-89E2A51A-8915-42D4-ACF3-4F79D25FAC55 Q36373813-42553B3D-6FC6-4758-A748-F441A2372770 Q36449229-7AB43975-5D67-414B-BAB4-7EC513E85E1A Q36474039-FA957428-DCE7-4427-816A-1936BA0CF626 Q36790753-0871A9E4-EE08-4095-9F87-B5831E689158 Q36856560-D3DC5A82-F5B3-4764-86C5-63528242BBE1 Q37024615-52704041-6A35-4518-B55E-1D70B206FE26 Q37057806-C6A095D7-8AFF-4E47-A31F-7D04CB57BADD Q37274056-C2C57925-236F-4812-9793-47553AEE1291 Q37298135-FE923E32-B41F-4B69-A2D5-6CF82659F79B Q37425957-23AC1557-FA1E-4B85-87F6-CC193DB0E7A7 Q37987146-0D4E992A-0498-4B93-B384-D1D394342886 Q38032481-D23BF298-F2FC-4CA6-A777-ECB467904788 Q38040993-1CB9ED17-13A3-487C-8E75-25777A71EA4C Q38105903-DFFDF9ED-8781-410A-839D-0ADEFF403A8E Q38119873-D1829E29-F63E-4550-B075-E0A4ACFC9BFD Q38165759-ADEBA024-5551-487E-9BC7-07E4EE02BCAA Q38170472-A68669A5-FDE8-402D-82F8-DD34560153C4 Q38264485-313F3C18-5713-4CA1-BEF9-95EF9EBBA493 Q38674162-299CB4C2-BAE2-4C7E-B809-7512E9C43779 Q38700215-49499B5C-C9EB-47CA-9FFD-7A367AD9E35D Q38709455-A6AB0AAA-3A66-4926-B84E-687E78BDB487 Q38774697-11A21E1A-D44D-45E8-8E2E-CF1057832FC0 Q38780130-C76D293C-5B9A-4C8C-A69B-304225BB1E07

P2860

Inflammation and adaptive immunity in Parkinson's disease.

http://www.wikidata.org/entity/Q37982378

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Inflammation and adaptive immunity in Parkinson's disease.

@en

Inflammation and adaptive immunity in Parkinson's disease.

@nl

type

label

Inflammation and adaptive immunity in Parkinson's disease.

@en

Inflammation and adaptive immunity in Parkinson's disease.

@nl

prefLabel

Inflammation and adaptive immunity in Parkinson's disease.

@en

Inflammation and adaptive immunity in Parkinson's disease.

@nl

P1433

Q37982378-F1EE1A55-B256-4F7E-B3D1-A24610F3E76C

P1476

Q37982378-43C5CFE3-1E7D-481F-9911-3C7C8A542555

P2093

Q37982378-34A39D59-F78A-4144-8370-B2B1B33EC442

Q37982378-3D81822F-37FB-48A2-88F4-683D925483B6

Q37982378-6CD73215-70E4-4963-A58D-1EFD104BAF65

Q37982378-A11CCD77-DE63-49DF-8541-46286DFEA7A4

P2860

Q37982378-048C0E27-9391-41D6-8834-3F1D2969F5B3

Q37982378-05B8803A-D8D1-43C8-8B8C-01DA770A751F

Q37982378-066F307B-AF31-42CE-A6C1-80116FC3A7CE

Q37982378-099E6F24-24A1-48FF-9BB7-A9DE1D0970F3

Q37982378-09B9AC85-236C-42D6-9FD6-AADD10D90CAE

Q37982378-0AF46727-7504-43F9-A24B-7A2B6DF9FDD6

Q37982378-0ECD77AD-D07E-400B-B96B-AE59A2441D9C

Q37982378-10F05618-E54C-48E9-B8FE-2546FA1CBF3A

Q37982378-123D003F-1276-4457-B58E-0D25D79EE3EE

Q37982378-12568B33-6905-46CC-86D7-A28588B53526

P304

Q37982378-AB4C67C3-9AB6-4512-9CA0-56C1C8801DDE

P31

Q37982378-EC61539C-65AE-46A6-B541-027855544E4C

P356

Q37982378-FEE8D8DB-9231-4287-80CD-BBFC54C76FC0

P433

Q37982378-CB0697C5-51D7-4C14-9B32-4D9C5535BCA9

P478

Q37982378-FB95825F-81B8-4C5C-8D46-C44E268BBAC6

P577

Q37982378-7D155D3E-D0F6-4426-AD79-D6CFB91312A7

P5875

Q37982378-E74F7179-9225-4804-A37C-C22A8A3EB24B

P698

Q37982378-E3EC4078-763C-4CED-962C-1EEA814ADDFC

P921

Q37982378-8E53CF3A-9437-456C-9032-22943A9A4778

Q37982378-A4CED098-81F7-4625-84F0-6E64DF9F190C

P932

Q37982378-CD6E1B0F-506F-4CE2-A322-A8621F589C89

P356

CSHPERSPECT.A009381

P1433

Cold Spring Harbor Perspectives in Medicine

P1476

Inflammation and adaptive immunity in Parkinson's disease.

@en

P2093

David K Stone

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Jessica A Hutter-Saunders

http://www.w3.org/2001/XMLSchema#string

R Lee Mosley

http://www.w3.org/2001/XMLSchema#string

P2860

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Role of microglia in central nervous system infections

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Control of regulatory T cell development by the transcription factor Foxp3

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein in Lewy bodies

P304

a009381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/CSHPERSPECT.A009381

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221815860

http://www.w3.org/2001/XMLSchema#string

P698

22315722

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3253034

http://www.w3.org/2001/XMLSchema#string